Eagle Pharmaceuticals Inc Says on May 28, Co Requested Hearing Before Hearings Panel of Nasdaq, Following Delisting Notice From Nasdaq - SEC Filing
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.